|
|
| | Dabuzalgron Basic information |
| Product Name: | Dabuzalgron | | Synonyms: | MethanesulfonaMide, N-[6-chloro-3-[(4,5-dihydro-1H-iMidazol-2-yl)Methoxy]-2-Methylphenyl]-;N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methyl-phenyl]me thanesulfonamide;Dabuzalgron;Ro 115-1240;membrane,potential,inhibit,Adrenergic Receptor,mitochondrial,urinary,Inhibitor,Beta Receptor,incontinence,Cell,Dabuzalgron,death,Apoptosis | | CAS: | 219311-44-1 | | MF: | C12H16ClN3O3S | | MW: | 317.79 | | EINECS: | | | Product Categories: | | | Mol File: | 219311-44-1.mol |  |
| | Dabuzalgron Chemical Properties |
| density | 1.46 | | storage temp. | Store at -20°C | | solubility | DMSO: 26 mg/mL (81.82 mM) |
| | Dabuzalgron Usage And Synthesis |
| Uses | Treatment of stress urinary incontinence. | | Definition | ChEBI: Dabuzalgron is a sulfonamide that is N-phenylmethanesulfonamide which carries a chloro group at position 2, 4,5-dihydro-1H-imidazol-2-ylmethoxy group at position 5, and a methyl group at position 6. Its is a selective alpha-adrenoceptor agonist that is used in the treatment of urinary incontinence. It has a role as an alpha-adrenergic agonist. It is a member of monochlorobenzenes, an aromatic ether, a sulfonamide and a member of imidazoles. |
| | Dabuzalgron Preparation Products And Raw materials |
|